Chester County News and Community Website
MALVERN, PA — Maxona Pharmaceuticals has announced the issuance of Patent No. 12,226,421 by the United States Patent and Trademark Office (USPTO) for MAX-001, the company’s breakthrough non-opioid, non-NSAID oral therapy …
Maxona Pharmaceuticals Secures New Patent for Innovative Pain Therapy Read More
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that the U.S. Food and Drug Administration (FDA) has issued a Refusal to File (RTF) letter for its supplemental …
Harmony Biosciences Faces Regulatory Setback, Outlines Future Plans for Pitolisant Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog (insulin aspart). This new treatment option, aimed at …
FDA Approves Groundbreaking Rapid-Acting Insulin Biosimilar Merilog, Offering New Hope for Millions Battling Diabetes Read More
PHOENIXVILLE, PA — PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, the company’s lead investigational asset aimed at mitigating Cannabis …
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal Syndrome Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain …
FDA Approves First-in-Class Non-Opioid Pain Drug Journavx Read More
RADNOR, PA — Advanced Aesthetic Technologies, Inc. (AAT) has announced that its partner in China, Lanzhou Biotechnique Development Co., Ltd. (LanDev), has secured regulatory approval to market Algeness® VL, a 2.5% …
Advanced Aesthetic Technologies’ Algeness VL Receives Approval in China Read More
MALVERN, PA — Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for OCU500, a novel …
Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced the authorization of 20 ZYN nicotine pouch products through its premarket tobacco product application (PMTA) pathway. This landmark …
FDA Grants First Marketing Authorizations for ZYN Nicotine Pouch Products Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture (USDA) is now accepting applications for the prestigious USDA 1890 National Scholars Program, a scholarship initiative aimed at fostering the next generation of …
USDA Opens Applications for 1890 National Scholars Program Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently released a draft guidance in collaboration with the Office for Human Research Protections, outlining recommendations for including tissue biopsies in …
FDA Issues Draft Guidance on Tissue Biopsies in Clinical Trials Read More